This inventor holds 6 USPTO granted patents and 18 published patent applications and 1 EPO patent. Top assignees: Marengo Therapeutics, Inc., Ablynx N.v.. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Cambridge, MA (US) (2023)
- Waltham, MA (US) (2022 - 2024)
Company Filing History:
Years Active: 2022-2025
Title: Innovations by Jonathan Hsu
Introduction
Jonathan Hsu is an accomplished inventor based in Waltham, MA (US). He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 6 patents, Hsu's work focuses on developing multifunctional molecules that target T cell-related cancer cells.
Latest Patents
Hsu's latest patents include groundbreaking inventions such as multifunctional molecules that bind to T cell-related cancer cells. These molecules consist of an antigen binding domain that interacts with T cell receptor beta chain constant domains, along with various components like immune cell engagers and cytokine molecules. Additionally, he has developed anti-TCR antibody molecules that bind to TCR Vβ regions, which are crucial for cancer treatment.
Career Highlights
Throughout his career, Jonathan Hsu has worked with notable companies such as Marengo Therapeutics, Inc. and Ablynx N.V. His expertise in the field has led to the development of innovative therapeutic solutions aimed at improving cancer treatment outcomes.
Collaborations
Hsu has collaborated with esteemed colleagues, including Seng-Lai Tan and Brian Edward Vash, to further advance his research and innovations in cancer therapies.
Conclusion
Jonathan Hsu's contributions to cancer treatment through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for innovative solutions in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
